Symbols / CAI Stock $20.20 +2.07% Caris Life Sciences, Inc.

Healthcare • Biotechnology • United States • NMS
CAI (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Dr. David Dean Halbert M.D.
Exch · Country NMS · United States
Market Cap 5.71B
Enterprise Value 5.34B
Income -537.96M
Sales 812.03M
FCF (ttm) 53.50M
Book/sh 2.04
Cash/sh 2.83
Employees 1,846
Insider 10d —
IPO Jun 18, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 53.65
PEG —
P/S 7.03
P/B 9.89
P/C —
EV/EBITDA 78.80
EV/Sales 6.57
Quick Ratio 7.16
Current Ratio 7.85
Debt/Eq 74.08
LT Debt/Eq —
EPS (ttm) -3.22
EPS next Y 0.38
EPS Growth —
Revenue Growth 125.40%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-02-26
ROA 3.84%
ROE -45.37%
ROIC —
Gross Margin 66.63%
Oper. Margin 30.19%
Profit Margin -8.39%
Shs Outstand 282.66M
Shs Float 96.51M
Insider Own 48.53%
Instit Own 51.28%
Short Float 10.23%
Short Ratio 4.48
Short Interest 11.79M
52W High 42.50
vs 52W High -52.47%
52W Low 16.28
vs 52W Low 24.08%
Beta —
Impl. Vol. 49.88%
Rel Volume 0.35
Avg Volume 2.38M
Volume 822.14K
Target (mean) $29.69
Tgt Median $30.00
Tgt Low $21.00
Tgt High $38.00
# Analysts 13
Recom Strong_buy
Prev Close $19.79
Price $20.20
Change 2.07%
About

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$29.69
Mean price target
2. Current target
$20.20
Latest analyst target
3. DCF / Fair value
$3.41
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$20.20
Low
$21.00
High
$38.00
Mean
$29.69

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-13 init Jefferies — → Buy $28
2026-04-10 init Piper Sandler — → Neutral $21
2026-04-06 main Evercore ISI Group Outperform → Outperform $30
2026-03-13 main Canaccord Genuity Hold → Hold $22
2026-02-27 main Evercore ISI Group Outperform → Outperform $34
2026-02-27 main Baird Outperform → Outperform $28
2026-02-27 main BTIG Buy → Buy $38
2026-02-17 init Baird — → Outperform $26
2025-12-22 main Canaccord Genuity Hold → Hold $30
2025-12-02 init Canaccord Genuity — → Hold $28
2025-08-13 main Guggenheim Buy → Buy $36
2025-08-13 main Evercore ISI Group Outperform → Outperform $40
2025-08-13 main Citigroup Buy → Buy $42
2025-07-15 init Evercore ISI Group — → Outperform $33
2025-07-14 init TD Cowen — → Buy $32
2025-07-14 init Guggenheim — → Buy $32
2025-07-14 init Wolfe Research — → Outperform $32
2025-07-14 init Citigroup — → Buy $34
2025-07-14 init JP Morgan — → Overweight $31
News
RSS: Latest CAI news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-06 HALBERT DAVID D Chief Executive Officer — 320,112 $0.00 $0
2026-03-06 BRILLE BRIAN J. Officer and Director — 83,162 $0.00 $0
2026-03-06 DENTON JOHN RUSSEL General Counsel — 63,971 $0.00 $0
2026-03-06 POWER LUKE THOMAS Chief Financial Officer — 63,971 $0.00 $0
2026-03-06 SPETZLER DAVID BAXLEY PH.D. President — 83,162 $0.00 $0
2026-02-26 CASTLEMAN PETER M Director — 5,509 $20.06 $110,511
2026-02-26 VACIRCA JEFF L Director — 2,492 $20.06 $49,990
2026-02-26 MINOR LLOYD B. Director — 2,492 $20.06 $49,990
2026-02-26 HALBERT JON S. Director — 2,492 $20.06 $49,990
2026-02-26 PHILLIPS T DANNY Director — 3,739 $20.06 $75,004
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
812.03
+96.97%
412.26
+34.67%
306.13
+18.43%
258.49
Operating Revenue
812.03
+96.97%
412.26
+34.67%
306.13
+18.43%
258.49
Cost Of Revenue
272.87
+16.87%
233.48
+7.68%
216.82
+21.49%
178.46
Reconciled Cost Of Revenue
272.87
+16.87%
233.48
+7.68%
216.82
+21.49%
178.46
Gross Profit
539.17
+201.58%
178.78
+100.18%
89.31
+11.61%
80.02
Operating Expense
494.06
+13.34%
435.90
+6.61%
408.86
+3.31%
395.78
Research And Development
101.58
-10.83%
113.92
-2.54%
116.88
+15.42%
101.27
Selling General And Administration
392.47
+21.89%
321.99
+10.28%
291.98
-0.86%
294.51
Selling And Marketing Expense
167.51
+9.77%
152.60
+6.77%
142.93
+3.30%
138.36
General And Administrative Expense
224.97
+32.81%
169.39
+13.64%
149.05
-4.55%
156.15
Salaries And Wages
—
12.75
+22.79%
10.38
—
Other Gand A
224.97
+32.81%
169.39
+13.64%
149.05
-4.55%
156.15
Total Expenses
766.92
+14.57%
669.38
+6.98%
625.68
+8.96%
574.24
Operating Income
45.11
+117.55%
-257.12
+19.54%
-319.55
-1.20%
-315.76
Total Operating Income As Reported
45.11
+117.55%
-257.12
+19.54%
-319.55
-1.20%
-315.76
EBITDA
11.38
+106.22%
-182.95
+29.85%
-260.80
-6.06%
-245.89
Normalized EBITDA
83.56
+141.48%
-201.44
+22.82%
-260.98
+2.12%
-266.65
Reconciled Depreciation
22.61
-53.76%
48.91
-0.18%
49.00
+1.55%
48.25
EBIT
-11.23
+95.15%
-231.87
+25.16%
-309.81
-5.32%
-294.15
Total Unusual Items
-72.18
-490.50%
18.48
+10226.26%
0.18
-99.14%
20.75
Total Unusual Items Excluding Goodwill
-72.18
-490.50%
18.48
+10226.26%
0.18
-99.14%
20.75
Special Income Charges
-19.89
0.00
+100.00%
-10.91
0.00
Other Special Charges
19.89
—
10.91
—
Net Income
-68.09
+75.85%
-281.89
+17.43%
-341.42
-6.42%
-320.83
Pretax Income
-68.09
+75.85%
-281.89
+17.43%
-341.42
-6.42%
-320.83
Net Non Operating Interest Income Expense
-40.36
+5.94%
-42.90
-110.80%
-20.35
+20.91%
-25.73
Interest Expense Non Operating
56.85
+13.65%
50.02
+58.26%
31.61
+18.48%
26.68
Net Interest Income
-40.36
+5.94%
-42.90
-110.80%
-20.35
+20.91%
-25.73
Interest Expense
56.85
+13.65%
50.02
+58.26%
31.61
+18.48%
26.68
Interest Income Non Operating
16.50
+131.63%
7.12
-36.74%
11.26
+1088.81%
0.95
Interest Income
16.50
+131.63%
7.12
-36.74%
11.26
+1088.81%
0.95
Other Income Expense
-72.84
-501.68%
18.14
+1299.40%
-1.51
-107.32%
20.66
Other Non Operating Income Expenses
-0.67
-90.54%
-0.35
+79.36%
-1.69
-1738.04%
-0.09
Gain On Sale Of Security
-52.28
-382.87%
18.48
+66.61%
11.09
-46.55%
20.75
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-68.09
+75.85%
-281.89
+17.43%
-341.42
-6.42%
-320.83
Net Income From Continuing Operation Net Minority Interest
-68.09
+75.85%
-281.89
+17.43%
-341.42
-6.42%
-320.83
Net Income From Continuing And Discontinued Operation
-68.09
+75.85%
-281.89
+17.43%
-341.42
-6.42%
-320.83
Net Income Continuous Operations
-68.09
+75.85%
-281.89
+17.43%
-341.42
-6.42%
-320.83
Normalized Income
4.09
+101.36%
-300.37
+12.07%
-341.59
0.00%
-341.58
Net Income Common Stockholders
-537.96
-42.22%
-378.26
+18.22%
-462.53
-15.68%
-399.83
Otherunder Preferred Stock Dividend
85.43
-11.35%
96.37
-20.43%
121.11
+53.30%
79.00
Diluted EPS
-3.22
-136.60%
-1.36
+25.03%
-1.82
-15.68%
-1.57
Basic EPS
-3.22
-136.60%
-1.36
+25.03%
-1.82
-15.68%
-1.57
Basic Average Shares
167.21
-39.84%
277.93
+9.08%
254.79
+0.00%
254.79
Diluted Average Shares
167.21
-39.84%
277.93
+9.08%
254.79
+0.00%
254.79
Diluted NI Availto Com Stockholders
-537.96
-42.22%
-378.26
+18.22%
-462.53
-15.68%
-399.83
Depreciation Amortization Depletion Income Statement
—
0.13
-74.40%
0.50
—
Depreciation And Amortization In Income Statement
—
0.13
-74.40%
0.50
—
Depreciation Income Statement
—
0.13
-74.40%
0.50
—
Preferred Stock Dividends
384.44
+0.00%
384.44
+217.42%
121.11
+53.30%
79.00
Rent And Landing Fees
—
6.74
-16.16%
8.04
—
Rent Expense Supplemental
—
8.38
-16.02%
9.98
—
Line Item Trend 2025-12-31
Total Assets
1,125.66
Current Assets
997.80
Cash Cash Equivalents And Short Term Investments
798.57
Cash And Cash Equivalents
796.27
Other Short Term Investments
2.29
Receivables
112.14
Accounts Receivable
112.14
Other Receivables
—
Inventory
63.62
Raw Materials
63.62
Prepaid Assets
19.59
Restricted Cash
1.52
Other Current Assets
2.35
Total Non Current Assets
127.86
Net PPE
63.17
Gross PPE
304.15
Accumulated Depreciation
-240.98
Properties
0.00
Machinery Furniture Equipment
134.11
Other Properties
106.23
Leases
63.81
Goodwill And Other Intangible Assets
19.34
Goodwill
19.34
Other Non Current Assets
45.35
Total Liabilities Net Minority Interest
548.36
Current Liabilities
127.14
Payables And Accrued Expenses
64.31
Payables
39.21
Accounts Payable
39.21
Current Accrued Expenses
25.11
Pensionand Other Post Retirement Benefit Plans Current
31.49
Current Debt And Capital Lease Obligation
6.53
Current Debt
—
Other Current Borrowings
—
Current Capital Lease Obligation
6.53
Current Deferred Liabilities
24.49
Current Deferred Revenue
24.49
Other Current Liabilities
0.33
Total Non Current Liabilities Net Minority Interest
421.21
Long Term Debt And Capital Lease Obligation
421.16
Long Term Debt
378.45
Long Term Capital Lease Obligation
42.71
Preferred Securities Outside Stock Equity
0.00
Stockholders Equity
577.31
Common Stock Equity
577.31
Capital Stock
0.28
Common Stock
0.28
Share Issued
284.14
Ordinary Shares Number
282.53
Treasury Shares Number
1.61
Additional Paid In Capital
3,141.72
Retained Earnings
-2,548.74
Gains Losses Not Affecting Retained Earnings
0.94
Treasury Stock
16.90
Other Equity Adjustments
0.94
Total Equity Gross Minority Interest
577.31
Total Capitalization
955.76
Working Capital
870.65
Invested Capital
955.76
Total Debt
427.69
Net Debt
—
Capital Lease Obligations
49.24
Net Tangible Assets
557.96
Tangible Book Value
557.96
Derivative Product Liabilities
0.05
Interest Payable
—
Other Equity Interest
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
83.16
+133.91%
-245.20
+11.19%
-276.10
+3.36%
-285.71
Cash Flow From Continuing Operating Activities
83.16
+133.91%
-245.20
+11.19%
-276.10
+3.36%
-285.71
Net Income From Continuing Operations
-68.09
+75.85%
-281.89
+17.43%
-341.42
-6.42%
-320.83
Depreciation Amortization Depletion
22.61
-53.76%
48.91
-0.18%
49.00
+1.55%
48.25
Depreciation And Amortization
22.61
-53.76%
48.91
-0.18%
49.00
+1.55%
48.25
Other Non Cash Items
19.57
+17.28%
16.69
+99.09%
8.38
+20.12%
6.98
Stock Based Compensation
70.01
+275.51%
18.64
+22.32%
15.24
-33.45%
22.90
Operating Gains Losses
19.89
—
10.91
—
Unrealized Gain Loss On Investment Securities
52.28
+382.87%
-18.48
-66.61%
-11.09
+46.55%
-20.75
Change In Working Capital
-33.13
-13.97%
-29.07
-307.73%
-7.13
+67.97%
-22.26
Change In Receivables
-29.79
+11.91%
-33.82
-124.23%
-15.08
-26.68%
-11.90
Changes In Account Receivables
-29.79
+11.91%
-33.82
-124.23%
-15.08
-26.68%
-11.90
Change In Inventory
-20.75
-480.11%
5.46
+223.09%
-4.43
+60.06%
-11.10
Change In Prepaid Assets
-5.15
-265.77%
-1.41
-130.99%
4.54
+228.22%
-3.54
Change In Payables And Accrued Expense
22.51
+3801.91%
0.58
-93.16%
8.43
+264.66%
2.31
Change In Accrued Expense
11.48
+1329.51%
0.80
-36.27%
1.26
+119.10%
-6.60
Change In Payable
11.04
+4982.74%
-0.23
-103.15%
7.17
-19.52%
8.91
Change In Account Payable
11.04
+4982.74%
-0.23
-103.15%
7.17
-19.52%
8.91
Change In Other Current Assets
0.05
-60.33%
0.12
+120.58%
-0.59
-129.64%
1.98
Investing Cash Flow
-16.26
-130.72%
52.93
-75.35%
214.77
+175.90%
-282.99
Cash Flow From Continuing Investing Activities
-16.26
-130.72%
52.93
-75.35%
214.77
+175.90%
-282.99
Net PPE Purchase And Sale
-16.26
-92.56%
-8.44
+62.17%
-22.32
+47.18%
-42.26
Purchase Of PPE
-16.26
-92.56%
-8.44
+62.17%
-22.32
+47.18%
-42.26
Capital Expenditure
-16.26
-92.56%
-8.44
+62.17%
-22.32
+47.18%
-42.26
Net Investment Purchase And Sale
0.00
-100.00%
61.38
-74.11%
237.09
+198.49%
-240.73
Purchase Of Investment
0.00
0.00
+100.00%
-63.40
+83.25%
-378.38
Sale Of Investment
0.00
-100.00%
61.38
-79.57%
300.49
+118.31%
137.65
Financing Cash Flow
664.99
+232.01%
200.29
+1876.83%
10.13
-3.00%
10.45
Cash Flow From Continuing Financing Activities
664.99
+232.01%
200.29
+1876.83%
10.13
-3.00%
10.45
Net Issuance Payments Of Debt
27.76
-86.11%
199.82
+1790.99%
10.57
+1198.44%
-0.96
Issuance Of Debt
27.86
-86.07%
199.98
+4.53%
191.31
0.00
Repayment Of Debt
-0.11
+32.48%
-0.16
+99.91%
-180.74
-18688.25%
-0.96
Long Term Debt Issuance
27.86
-86.07%
199.98
+4.53%
191.31
0.00
Long Term Debt Payments
-0.11
+32.48%
-0.16
+99.91%
-180.74
-18688.25%
-0.96
Net Long Term Debt Issuance
27.76
-86.11%
199.82
+1790.99%
10.57
+1198.44%
-0.96
Net Common Stock Issuance
528.35
0.00
0.00
—
Common Stock Payments
-0.11
0.00
0.00
—
Repurchase Of Capital Stock
-0.11
0.00
0.00
—
Proceeds From Stock Option Exercised
17.91
+1070.39%
1.53
-17.96%
1.86
-83.65%
11.41
Net Other Financing Charges
-30.26
-2757.51%
-1.06
+53.96%
-2.30
—
Changes In Cash
731.88
+9020.05%
8.03
+115.68%
-51.19
+90.83%
-558.25
Effect Of Exchange Rate Changes
0.13
+3350.00%
-0.00
-106.45%
0.06
+3000.00%
0.00
Beginning Cash Position
68.03
+13.37%
60.01
-46.01%
111.14
-83.40%
669.38
End Cash Position
800.04
+1076.05%
68.03
+13.37%
60.01
-46.01%
111.14
Free Cash Flow
66.89
+126.37%
-253.64
+15.00%
-298.42
+9.01%
-327.96
Interest Paid Supplemental Data
43.52
-11.21%
49.02
+210.71%
15.78
-34.92%
24.24
Common Stock Issuance
528.46
0.00
0.00
—
Issuance Of Capital Stock
649.70
0.00
0.00
—
Net Preferred Stock Issuance
121.24
0.00
0.00
—
Preferred Stock Issuance
121.24
0.00
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category